Morgan Stanley Regencell Bioscience Holdings LTD Transaction History
Morgan Stanley
- $1.36 Trillion
- Q1 2025
A detailed history of Morgan Stanley transactions in Regencell Bioscience Holdings LTD stock. As of the latest transaction made, Morgan Stanley holds 5 shares of RGC stock, worth $3,124. This represents 0.0% of its overall portfolio holdings.
Number of Shares
5
Previous 2,100
99.76%
Holding current value
$3,124
Previous $10,000
100.0%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding RGC
# of Institutions
6Shares Held
8.71KCall Options Held
0Put Options Held
0-
Geode Capital Management, LLC Boston, MA6.82KShares$4.26 Million0.0% of portfolio
-
Royal Bank Of Canada Toronto, A6948Shares$592,4520.0% of portfolio
-
Tower Research Capital LLC (Trc) New York, NY698Shares$436,2150.0% of portfolio
-
Black Rock Inc. New York, NY238Shares$148,7380.0% of portfolio
-
Concourse Financial Group Securities, Inc. Birmingham, AL0Shares$0100.0% of portfolio
About Regencell Bioscience Holdings Ltd
- Ticker RGC
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 13,012,900
- Market Cap $8.13B
- Description
- Regencell Bioscience Holdings Limited operates a Traditional Chinese medicine (TCM) bioscience company. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily attention deficit hyperactivity disorder and autism spectrum disorder. The company was incorporated...